News
Consumer Reports and Unleaded Kids evaluated baby food brands for compliance with California’s AB899 requiring heavy metal ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
Pharmexcil warns US tariffs on Indian pharmaceuticals would harm American consumers. India is a key supplier of affordable generics.
Generated LUMRYZ™ net revenue of $68.1 million, a 64% increase compared to second quarter 2024, net income of $9.7 million and earnings per share of $0.10 ---- 3,100 patients on LUMRYZ as of June 30, ...
25m
Verywell Health on MSNLilly’s Oral GLP-1 Drug Shows Modest Weight Loss Results Compared to InjectablesA daily oral GLP-1 pill can help people with obesity lose about 12% of their body weight, according to early data shared by drugmaker Eli Lilly today. The medication, called orforglipron, may be a ...
43m
Press Trust of India on MSNIntas Pharmaceuticals and Accord BioPharma Become One of the Largest Global Suppliers of Pegfilgrastim with Acquisition of UDENYCA®A HMEDABAD, India, Aug. 6, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world's ...
When it comes to compounded Ozempic and other semaglutides, Dr. Goulden adds that they are not identical to their ...
Gilead has returned the rights to a cancer candidate it licensed from Arcus Biosciences in a $725 million, multiprogram deal, ...
A supplier provided "incorrect ingredients" for the items sold across the United States, Mexico and Ecuador, the FDA said.
The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results